Golimumab bulk supplier for pharma manufacturers

Golimumab Suppliers & Bulk Manufacturers

Available Forms: injection (prefilled syringe)

Available Strengths: 50 mg / 0.5 mL, 100 mg / 1 mL

Reference Brands: Simponi (USA/EU)

Golimumab is a human monoclonal antibody that acts as a tumor necrosis factor-alpha (TNF-α) inhibitor. It works by binding to and neutralizing TNF-α, a pro-inflammatory cytokine involved in autoimmune and inflammatory processes. Golimumab is used in the treatment of immune-mediated disorders such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. It is available as subcutaneous injections (prefilled syringe or autoinjector) and intravenous infusion formulations.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Golimumab — third party manufacturing & bulk supply

Golimumab is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Golimumab is supplied as injection (prefilled syringe) — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Golimumab listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Golimumab →

Back to Listing

Frequently Asked Questions

Golimumab is listed as injection (prefilled syringe) in 50 mg / 0.5 mL, 100 mg / 1 mL. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Golimumab is referenced against Simponi (USA/EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.